ADMA BIOLOGICS, INC.·4

Feb 21, 9:05 PM ET

Guiheen Lawrence P. 4

4 · ADMA BIOLOGICS, INC. · Filed Feb 21, 2025

Insider Transaction Report

Form 4
Period: 2025-02-19
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-19+16,27916,279 total
    Exercise: $16.07Exp: 2035-02-19Common Stock (16,279 underlying)
  • Award

    Common Stock

    2025-02-19+10,889164,830 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,000
Footnotes (4)
  • [F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
  • [F2]Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 restricted stock units granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (iii) 141,921 shares of common stock owned by the Reporting Person.
  • [F3]These shares are owned by the Guiheen Trust, of which the Reporting Person serves as a joint trustee.
  • [F4]The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4